Universität Rostock

University / College


Location: Rostock, Germany (DE) DE

ISNI: 0000000121858338

ROR: https://ror.org/03zdwsf69

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Treatment choices and neuropsychological symptoms of a large cohort of early MS (2018) Von Bismarck O, Dankowski T, Ambrosius B, Hessler N, Antony G, Ziegler A, Hoshi MM, et al. Journal article Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions (2018) Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Hellwig K, Pache F, et al. Journal article Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controls (2018) Denk J, Oberhauser F, Kornhuber J, Wiltfang J, Fassbender K, Schroeter ML, Volk AE, et al. Journal article Serum neurofilament light chain in behavioral variant frontotemporal dementia (2018) Steinacker P, Anderl-Straub S, Diehl-Schmid J, Semler E, Uttner I, Von Arnim CAF, Barthel H, et al. Journal article Atrophy in the Thalamus But Not Cerebellum Is Specific for FTD and ALS Patients - An Atlas-Based Volumetric MRI Study (2018) Schoenecker S, Neuhofer C, Otto M, Ludolph A, Kassubek J, Landwehrmeyer B, Anderl-Straub S, et al. Journal article A Modified Reading the Mind in the Eyes Test Predicts Behavioral Variant Frontotemporal Dementia Better Than Executive Function Tests (2018) Schroeter ML, Pawelke S, Bisenius S, Kynast J, Schuemberg K, Polyakova M, Anderl-Straub S, et al. Journal article A language-based sum score for the course and therapeutic intervention in primary progressive aphasia (2018) Semler E, Anderl-Straub S, Uttner I, Diehl-Schmid J, Danek A, Einsiedler B, Fassbender K, et al. Journal article BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study (2018) Fasching P, Loibl S, Hu C, Hart SN, Shimelis H, Moore R, Schem C, et al. Journal article Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixto (2018) Loibl S, Weber KE, Timms KM, Elkin EP, Hahnen E, Fasching P, Lederer B, et al. Journal article Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis (2018) Marquardt S, Solanki M, Spitschak A, Vera J, Puetzer BM Journal article